TY - JOUR
T1 - Exosomal ncRNAs in liquid biopsies for lung cancer
AU - Sadique Hussain, Md
AU - Gupta, Gaurav
AU - Ghaboura, Nehmat
AU - Moglad, Ehssan
AU - Hassan Almalki, Waleed
AU - Alzarea, Sami I.
AU - Kazmi, Imran
AU - Ali, Haider
AU - MacLoughlin, Ronan
AU - Loebenberg, Raimar
AU - Davies, Neal M.
AU - Kumar Singh, Sachin
AU - Dua, Kamal
N1 - Publisher Copyright:
© 2024 Elsevier B.V.
PY - 2025/1/15
Y1 - 2025/1/15
N2 - Exosomal non-coding RNAs (ncRNAs) have become essential contributors to advancing and treating lung cancers (LCs). The development of liquid biopsies that utilize exosomal ncRNAs (exo-ncRNAs) offers an encouraging method for diagnosing, predicting, and treating LC. This thorough overview examines the dual function of exo-ncRNAs as both indicators for early diagnosis and avenues for LC treatment. Exosomes are tiny vesicles secreted by various cells, including cancerous cells, enabling connection between cells by delivering ncRNAs. These ncRNAs, which encompass circular RNAs, long ncRNAs, and microRNAs, participate in the modulation of gene expression and cellular functions. In LC, certain exo-ncRNAs are linked to tumour advancement, spread, and treatment resistance, positioning them as promising non-invasive indicators in liquid biopsies. Additionally, targeting these ncRNAs offers potential for innovative treatment approaches, whether by suppressing harmful ncRNAs or reinstating the activity of tumour-suppressing ones. This review emphasizes recent developments in the extraction and analysis of exo-ncRNAs, their practical applications in LC treatment, and the challenges and prospects for translating these discoveries into clinical usage. Through this detailed examination of the current state of the art, we aim to highlight the significant potential of exo-ncRNAs for LC diagnostics and treatments.
AB - Exosomal non-coding RNAs (ncRNAs) have become essential contributors to advancing and treating lung cancers (LCs). The development of liquid biopsies that utilize exosomal ncRNAs (exo-ncRNAs) offers an encouraging method for diagnosing, predicting, and treating LC. This thorough overview examines the dual function of exo-ncRNAs as both indicators for early diagnosis and avenues for LC treatment. Exosomes are tiny vesicles secreted by various cells, including cancerous cells, enabling connection between cells by delivering ncRNAs. These ncRNAs, which encompass circular RNAs, long ncRNAs, and microRNAs, participate in the modulation of gene expression and cellular functions. In LC, certain exo-ncRNAs are linked to tumour advancement, spread, and treatment resistance, positioning them as promising non-invasive indicators in liquid biopsies. Additionally, targeting these ncRNAs offers potential for innovative treatment approaches, whether by suppressing harmful ncRNAs or reinstating the activity of tumour-suppressing ones. This review emphasizes recent developments in the extraction and analysis of exo-ncRNAs, their practical applications in LC treatment, and the challenges and prospects for translating these discoveries into clinical usage. Through this detailed examination of the current state of the art, we aim to highlight the significant potential of exo-ncRNAs for LC diagnostics and treatments.
KW - Cancer indicators
KW - Diagnosis
KW - Liquid biopsies
KW - Lung cancer
KW - Prognosis
KW - Therapeutic targets
UR - http://www.scopus.com/inward/record.url?scp=85205469138&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2024.119983
DO - 10.1016/j.cca.2024.119983
M3 - Review article
C2 - 39368685
AN - SCOPUS:85205469138
SN - 0009-8981
VL - 565
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
M1 - 119983
ER -
